The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Plasma lipoproteins: genetic influences and clinical implications
Abstract
Susceptibility to the growing global public health problem of cardiovascular disease is associated with levels of plasma lipids and lipoproteins. Several experimental strategies have helped us to clarify the genetic architecture of these complex traits, including classical studies of monogenic dyslipidaemias, resequencing, phenomic analysis and, more recently, genome-wide association studies and analysis of metabolic networks. The genetic basis of plasma lipoprotein levels can now be modelled as a mosaic of contributions from multiple DNA sequence variants, both rare and common, with varying effect sizes. In addition to filling gaps in our understanding of plasma lipoprotein metabolism, the recent genetic advances will improve our ability to classify, diagnose and treat dyslipidaemias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“elevated plasma LDL-C and TG levels are major risk factors (Defesche et al., 2017; Do et al., 2013; Hegele, 2009; Hokanson and Austin, 1996; Rader, 2016)”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Hegele, 2009
In the citing paper
“In humans and mice, genetic APOB variants associated with increased levels of apoB are also associated with unusually high plasma concentrations of cholesterol and LDL, which in turn contribute to hypercholesterolemia and heart disease in humans (Benn, 2009; Hegele, 2009).”
From Population genomics reveal recent speciation and rapid evolutionary adaptation in polar bears (2014) · cites this paper as Hegele, 2009
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,377
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Cited by
Sorted by citations
Items 101–200 of 472
Lipid metabolism and retinal diseases
Gabrielle, P. (2022) · Acta Ophthalmologica · doi:10.1111/aos.15226 · Cited by 50
Munawar, T., Mukhtar, F., Nadeem, M. S., Manzoor, S., Ashiq, M. N., Riaz, M., Batool, S., Hasan, M., & Iqbal, F. (2022) · Ceramics International · doi:10.1016/j.ceramint.2022.03.206 · Cited by 48
Yang, A., Gyulay, G., Mitchell, M., White, E. J., Trigatti, B. L., & Igdoura, S. A. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027300 · Cited by 49
Abdullah, M. M. H., Jones, P. J. H., & Eck, P. K. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv016 · Cited by 47
Structural stability and functional remodeling of high‐density lipoproteins
Gursky, O. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.028 · Cited by 48
Li, Z., Votava, J. A., Zajac, G. J. M., Nguyen, J. N., Jaimes, F. L., Ly, S. M., Brinkman, J. A., Giorgi, M. D., Kaul, S., Green, C. L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.015 · Cited by 47
Atypical plasma lipid profile in cancer patients: Cause or consequence?
Munir, R., Usman, H., Hasnain, S., Smans, K. A., Kalbacher, H., & Zaidi, N. (2014) · Biochimie · doi:10.1016/j.biochi.2014.03.010 · Cited by 45
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.20 · Cited by 48
Gargalovic, P. S., Erbilgin, A., Omid Kohannim, A., Pagnon, J. C., Wang, X., Castellani, L. W., LeBoeuf, R. C., Peterson, M. L., Spear, B. T., & Lusis, A. J. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.902320 · Cited by 44
Blackett, P. R., & Sanghera, D. K. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.079 · Cited by 47
Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
Gregersen, I., Høibraaten, E., Holven, K. B., Løvdahl, L., Ueland, T., Mowinckel, M., Dahl, T. B., Aukrust, P., Halvorsen, B. L., & Sandset, P. M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.10.005 · Cited by 44
Stanciulescu, L. A., Scafa‐Udriște, A., & Dorobanţu, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076669 · Cited by 45
Schierer, A., Been, L. F., Ralhan, S. K., Wander, G. S., Aston, C. E., & Sanghera, D. K. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834dc9ef · Cited by 43
Sortilin: An unusual suspect in cholesterol metabolism
Dubé, J. B., Johansen, C. T., & Hegele, R. A. (2011) · BioEssays · doi:10.1002/bies.201100003 · Cited by 43
Self-citationApolipoprotein E Effects on Mammalian Ovarian Steroidogenesis and Human Fertility
Oriá, R. B., de Almeida, J. Z., Moreira, C. N., Guerrant, R. L., & Figueiredo, J. R. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.06.003 · Cited by 45
Petkevičienė, J., Smalinskienė, A., Lukšienė, D., Jurėnienė, K., Ramažauskienė, V., Klumbienė, J., & Lesauskaitė, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041525 · Cited by 42
A new, powerful player in lipoprotein metabolism: brown adipose tissue
Bartelt, A., Merkel, M., & Heeren, J. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0858-3 · Cited by 45
Thurberg, B. L., Díaz, G. A., Lachmann, R., Schiano, T. D., Wasserstein, M., Ji, A., Zaher, A., & Peterschmitt, M. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.06.010 · Cited by 41
Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia
Sharma, K., kumar, K. P. S., & Mishra, N. (2014) · Drug Delivery · doi:10.3109/10717544.2014.920937 · Cited by 41
Superko, H. R., Momary, K. M., & Li, Y. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.11.004 · Cited by 41
The role of CREB-H transcription factor in triglyceride metabolism
Lee, A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283508fed · Cited by 40
Lipids and Diabetic Retinopathy
Modjtahedi, B. S., Bose, N., Papakostas, T. D., Morse, L. S., Vavvas, D. G., & Kishan, A. U. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1114869 · Cited by 41
Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
Gan, C., Wang, J., Martínez-Chávez, A., Hillebrand, M. J. X., de Vries, N., Beukers, J., Wagenaar, E., Wang, Y., Lebre, M. C., Rosing, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.017 · Cited by 39
García‐Ríos, A., Alcala-Diaz, J. F., Gómez-Delgado, F., Delgado‐Lista, J., Marı́n, C., Leon‐Acuña, A., Camargo, A., Rodríguez-Cantalejo, F., Blanco-Rojo, R., Quintana‐Navarro, G. M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.011 · Cited by 39
Calcaterra, I. L., Lupoli, R., Minno, A. D., & Minno, M. N. D. D. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13841 · Cited by 38
Effects of Lipoproteins on Metabolic Health
Albitar, O., D’Souza, C. M., & Adeghate, E. A. (2024) · Nutrients · doi:10.3390/nu16132156 · Cited by 41
Bhaskar, S., Ganesan, M., Chandak, G. R., Mani, R., Idris, M. M., Khaja, N., Gulla, S., Kumar, U., Movva, S., Vattam, K. K., et al. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0207 · Cited by 36
Dai, D., Chen, B., Wang, B., Tang, H., Li, X., Zhao, Z., Li, X., Xie, X., & Wei, W. (2016) · Journal of Cancer · doi:10.7150/jca.15776 · Cited by 36
Dyslipidemias in clinical practice
Cabezas, M. C., Burggraaf, B., & Klop, B. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.010 · Cited by 36
The effect of oral lipids and circulating lipoproteins on the metabolism of drugs
Patel, J. P., & Brocks, D. R. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903176439 · Cited by 36
Association of Genetic Loci with Blood Lipids in the Chinese Population
Zhang, Z., Tao, L., Chen, Z., Zhou, D., Kan, M., Zhang, D., Li, C., He, L., & Liu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027305 · Cited by 35
Valcárcel, B., Würtz, P., al Basatena, N.-K. S., Tukiainen, T., Kangas, A. J., Soininen, P., Järvelin, M., Ala‐Korpela, M., Ebbels, T. M. D., & Iorio, M. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024702 · Cited by 35
Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?
Alfonsi, J., Hegele, R. A., & Gryn, S. E. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0573-6 · Cited by 35
Self-citationParagh, G., Németh, Á., Harangi, M., Banach, M., & Fülöp, P. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01631-z · Cited by 35
Crawford, D. C., Dumitrescu, L. C., Goodloe, R., Brown-Gentry, K. D., Boston, J., McClellan, B., Sutcliffe, C. B., Wiseman, R., Baker, P. G., Pericak‐Vance, M. A., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000369 · Cited by 36
Jin, J., Sun, D., Cao, Y., Zhang, H., Guo, Y., Wu, N., Zhu, C., Gao, Y., Dong, Q., Liu, G., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.001 · Cited by 34
Hebbar, P., Nizam, R., Melhem, M., Alkayal, F., Elkum, N. B., John, S. E., Tuomilehto, J., Alsmadi, O. A., & Thanaraj, T. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p080218 · Cited by 34
Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly
LUCCHI, T. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07347-x · Cited by 33
Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control
Singla, S., Kaur, K., Kaur, G., Kaur, H., Kaur, J., & Jaswal, S. (2009) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.53125 · Cited by 33
Pediatric Dyslipidemia—Beyond Familial Hypercholesterolemia
Lazarte, J., & Hegele, R. A. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.03.020 · Cited by 32
Self-citationHegele, R. A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.c070946 · Cited by 31
Self-citationBrain education-based meditation for patients with hypertension and/or type 2 diabetes
Lee, S.-H., Hwang, S.-M., Kang, D., & Yang, H. (2019) · Medicine · doi:10.1097/md.0000000000015574 · Cited by 34
Are elite endurance athletes genetically predisposed to lower disease risk?
Gómez‐Gallego, F., Ruiz, J. R., Buxens, A., Altmäe, S., Artieda, M., Santiago, C., González‐Freire, M., Verde, Z., Arteta, D., Martínez‐Amat, A., et al. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00183.2009 · Cited by 34
Genetic Testing in Hyperlipidemia
Bilen, O., Pokharel, Y., & Ballantyne, C. M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.009 · Cited by 30
von Eckardstein, A. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.6 · Cited by 30
Integrating post-genomic approaches as a strategy to advance our understanding of health and disease
Tang, J. P., Tan, C. E., Orešič, M., & Vidal‐Puig, A. (2009) · Genome Medicine · doi:10.1186/gm35 · Cited by 30
Wang, X., Ding, X., Su, S., Spector, T. D., Mangino, M., Iliadou, A. N., & Snieder, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1524-3 · Cited by 30
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
Pamir, N., Pan, C., Plubell, D. L., Hutchins, P. M., Tang, C., Wimberger, J., Irwin, A. D., Vallim, T. Q. D. A., Heinecke, J. W., & Lusis, A. J. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m090555 · Cited by 29
Thurberg, B. L., Wasserstein, M., Jones, S. A., Schiano, T. D., Cox, G. F., & Puga, A. C. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000659 · Cited by 29
Hou, J., Deng, Q., Guo, X., Deng, X., Zhong, W. H., & Zhong, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01323-6 · Cited by 29
Nutrigenetics of the lipoprotein metabolism
García‐Ríos, A., Pérez‐Martínez, P., Delgado‐Lista, J., López‐Miranda, J., & Pérez‐Jiménez, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100513 · Cited by 28
Effects of hawthorn seed oil on plasma cholesterol and gut microbiota
Kwek, E., Yan, C., Ding, H., Hao, W., He, Z., Liu, J., Ma, K. Y., Zhu, H., & Chen, Z. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00690-4 · Cited by 28
Soh, J., Josekutty, J., & Hussain, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00017-8 · Cited by 28
Cholesterol Levels in Patients with Chronic Lymphocytic Leukemia
Yavaşoğlu, İ., Sargın, G., Yılmaz, F., Altındag, S., Akgün, G., Tombak, A., Toka, B., Sinan, D. A. L., Özbaş, H. M., Çetin, G., et al. (2017) · Journal of the National Medical Association · doi:10.1016/j.jnma.2016.11.006 · Cited by 28
Apolipoprotein C1 regulates epiboly during gastrulation in zebrafish
Wang, Y., Zhou, L., Li, Z., Li, W., & Gui, J. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4563-4 · Cited by 27
Fu, J. M., Kwok, S., Sinai, L., Abdel‐Razek, O., Babula, J., Chen, D., Farago, E., Fernandopulle, N., Leith, S. J., Loyzer, M. N., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.01.008 · Cited by 27
Self-citationHepatitis C virus–apolipoprotein interactions: molecular mechanisms and clinical impact
Crouchet, É., Baumert, T. F., & Schuster, C. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1344102 · Cited by 27
Mutation in ST6GALNAC5 identified in family with coronary artery disease
InanlooRahatloo, K., Parsa, A. F. Z., Huse, K., Rasooli, P., Davaran, S., Platzer, M., Kramer, M., Fan, J., Turk, C., Amini, S., et al. (2014) · Scientific Reports · doi:10.1038/srep03595 · Cited by 27
de Miranda, A. M., Rossoni, J. V., Silva, L. S. E., dos Santos, R. C., Silva, M. E., & Pedrosa, M. L. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1217-x · Cited by 27
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
Zhou, Y., Mägi, R., Milani, L. A., & Lauschke, V. M. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p086710 · Cited by 28
Huang, X., Wei, X., Qiao, S., Zhang, X., Li, R. Q., Hu, S., Mao, H., & Liu, P. (2021) · Cancer Management and Research · doi:10.2147/cmar.s337873 · Cited by 26
Genetic Determinants of Major Blood Lipids in Pakistanis Compared With Europeans
Saleheen, D., Soranzo, N., Rasheed, A., Scharnagl, H., Gwilliam, R., Alexander, M., Inouye, M., Zaidi, M. A., Potter, S., Haycock, P., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.906180 · Cited by 26
Zhou, H., Ding, X., Yang, Q., Chen, S., Li, Y., Zhou, X., & Wu, S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026632 · Cited by 25
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events
Raggi, P., Becciu, M. L., & Navarese, E. P. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000921 · Cited by 25
Staiano, A., Taranto, M. D. D., Bloise, E., D’Agostino, M. N., D’Angelo, A., Marotta, G., Gentile, M., Jossa, F., Iannuzzi, A., Rubba, P., et al. (2012) · Smart innovation, systems and technologies · doi:10.1007/978-3-642-35467-0_18 · Cited by 25
Walker, C. G., Loos, R. J. F., Olson, A. D., Frost, G. S., Griffin, B. A., Lovegrove, J. A., Sanders, T. A. B., & Jebb, S. A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.039 · Cited by 27
Huang, X. H., Zhao, J., & Zhao, T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.043 · Cited by 25
Cardiovascular diseases and genome-wide association studies
Ndiaye, N. C., Azimi–Nezhad, M., Shamieh, S. E., Stathopoulou, M. G., & Visvikis‐Siest, S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.035 · Cited by 26
Khovidhunkit, W., Charoen, S., Kiateprungvej, A., Chartyingcharoen, P., Muanpetch, S., & Plengpanich, W. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.11.007 · Cited by 24
Lin, M., Wang, Z., Wang, D., Chen, X., & Zhang, J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05337 · Cited by 24
Tao, L., Zhang, Z., Chen, Z., Zhou, D., Li, W., Kan, M., Zhang, D., He, L., Huang, G., & Liu, Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1476-4 · Cited by 24
Homeostasis and dyshomeostasis of the retina
Zhang, C.-J., & Jin, Z. (2023) · Current Medicine · doi:10.1007/s44194-023-00021-6 · Cited by 25
Sanghera, D. K., Been, L. F., Ralhan, S. K., Wander, G. S., Mehra, N. K., Singh, J. R., Ferrell, R. E., Kamboh, M. I., & Aston, C. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021188 · Cited by 23
Genetic Determinants of “Cognitive Impairment, No Dementia”
Dubé, J. B., Johansen, C. T., Robinson, J. F., Lindsay, J., Hachinski, V., & Hegele, R. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121477 · Cited by 23
Self-citationGenetic architecture of circulating lipid levels
Demirkan, A., Amin, N., Isaacs, A. J., Järvelin, M., Whitfield, J. B., Wichmann, H. ‐., Kyvik, K. O., Rudan, I., Gieger, C., Hicks, A. A., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.21 · Cited by 22
Hu, X., Fan, J., Ma, Q., Han, L., Cao, Z., Xu, C., Luan, J., Jing, G., Nan, Y., Wu, T., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01456-z · Cited by 22
Increased expression of ApoA1 after neuronal injury may be beneficial for healing
Sengupta, M. B., Saha, S. G., Mohanty, P. K., Mukhopadhyay, K. K., & Mukhopadhyay, D. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2841-8 · Cited by 22
Signatures of natural selection on genetic variants affecting complex human traits
Zhang, G., Muglia, L. J., Chakraborty, R., Akey, J. M., & Williams, S. M. (2013) · Applied & Translational Genomics · doi:10.1016/j.atg.2013.10.002 · Cited by 25
Sanecka-Duin, A., Ansems, M., Hout-Kuijer, M. A. V., Looman, M. W. G., Prosser, A., Welten, S. P. M., Gilissen, C., Sama, I. E., Huynen, M. A., Veltman, J. A., et al. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.12.003 · Cited by 22
The Impact of Acute Nutritional Interventions on the Plasma Proteome
Vernardis, S. I., Demichev, V., Lemke, O., Grüning, N., Messner, C. B., White, M. E. H., Pietzner, M., Peluso, A., Collet, T., Henning, E., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad031 · Cited by 20
Catalina Dussaillant, K., Serrano, V., Alberto Maiz, G., Eyheramendy, S., Cataldo, L. R., Chavez, M., Smalley, S. V., Fuentes, M., Rigotti, A., Rubio, L., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-106 · Cited by 20
High prevalence of an anti-hypertriglyceridemic variant of the MLXIPL gene in Central Asia
Nakayama, K., Yanagisawa, Y., Ogawa, A., Ishizuka, Y., Munkhtulga, L., Charupoonphol, P., Supannatas, S., Kuartei, S. J., Chimedregzen, U., Koda, Y., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.109 · Cited by 20
Tgif1 represses apolipoprotein gene expression in liver
Melhuish, T. A., Chung, D. D., Bjerke, G. A., & Wotton, D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22713 · Cited by 20
Hesse, D., Radloff, K., Jaschke, A., Lagerpusch, M., Chung, B., Tailleux, A., Staels, B., & Schürmann, A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040089 · Cited by 20
Range of SHH signaling in adrenal gland is limited by membrane contact to cells with primary cilia
Mateska, I., Nanda, K., Dye, N. A., Alexaki, V. I., & Eaton, S. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201910087 · Cited by 21
Ke, J.-F., Wang, J., Zhang, Z., Chen, M., Lu, J., & Li, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.599545 · Cited by 20
Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity
Brisson, D., Larouche, M., Chebli, J., Khoury, É., & Gaudet, D. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.02.002 · Cited by 19
Low cholesterol states: clinical implications and management
Gill, P. K., & Hegele, R. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2204932 · Cited by 19
Self-citationKotzka, J., Knebel, B., Janssen, O. E., Schaefer, J. R., Soufi, M., Jacob, S., Nitzgen, U., & Müller‐Wieland, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.008 · Cited by 19
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
Kassim, S. H., Wilson, J. M., & Rader, D. J. (2010) · Clinical Lipidology · doi:10.2217/clp.10.73 · Cited by 19
Cross-species data integration to prioritize causal genes in lipid metabolism
Votava, J. A., & Parks, B. W. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000742 · Cited by 19
Predictive genetic testing for coronary artery disease
Johansen, C. T., & Hegele, R. A. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/07388550903422075 · Cited by 18
Self-citationAssociations of triglyceride levels with longevity and frailty: A Mendelian randomization analysis
Liu, Z., Burgess, S., Wang, Z., Deng, W., Chu, X., Cai, J., Zhu, Y., Shi, J., Xie, X., Wang, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep41579 · Cited by 19
Mika, M., Antończyk, A., & Wikiera, A. (2023) · Polish Journal of Food and Nutrition Sciences · doi:10.31883/pjfns/161366 · Cited by 17
Sterols and immune mechanisms in asthma
Britt, R. D., Porter, N. A., Grayson, M. H., Gowdy, K. M., Ballinger, M. N., Wada, K. J., Kim, H., & Guerau‐de‐Arellano, M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.025 · Cited by 17
Genetic and Non-genetic Determinants of Cardiovascular Disease in South Asians
Goyal, S., & Sanghera, D. K. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210118103022 · Cited by 16
O’Neil, E. V., & Spencer, T. E. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab053 · Cited by 16
Shin, K. C., Huh, J. Y., Ji, Y., Han, J. S., Han, S. M., Park, J., Nahmgoong, H., Lee, W. T., Jeon, Y. G., Kim, B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111806 · Cited by 16
Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease
Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16
Microfluidic Dielectrophoretic Purification of Extracellular Vesicles from Plasma Lipoproteins
del Río, J. S., Son, Y., Park, J., Sunkara, V., & Cho, Y. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c02098 · Cited by 15
Metadata
- Authors
- Hegele, R. A.
- Affiliations
- Western University (CA)
- Corresponding author
- Hegele, Robert A.
- ORCID
- Hegele, Robert A.
- Venue
- Nature Reviews Genetics
- Published
- 2009-02
- Volume
- 10
- Issue
- 2
- Pages
- 109-121
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2068700927
- Cited by
- 462
- References
- 107
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 19 · 2023: 21 · 2022: 32 · 2021: 22 · 2020: 24 · 2019: 19 · 2018: 27 · 2017: 19 · 2016: 31 · 2015: 33 · 2014: 36 · 2013: 26 · 2012: 31
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- serum lipoproteins, plasma lipids, genetic architecture, cardiovascular risk, dyslipidemia, genome-wide association study, rare variants, lipid metabolism, metabolic networks, phenomics, resequencing, disease diagnosis and treatment
- MeSH terms
- Animals, Cholesterol, Humans, Hyperlipoproteinemias, Lipoproteins, Models, Biological, Triglycerides, Genomics, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review